Vanguard Group Inc Cerus Corp Transaction History
Vanguard Group Inc
- $5.97 Trillion
- Q2 2025
A detailed history of Vanguard Group Inc transactions in Cerus Corp stock. As of the latest transaction made, Vanguard Group Inc holds 10,721,323 shares of CERS stock, worth $13.2 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,721,323
Previous 10,553,236
1.59%
Holding current value
$13.2 Million
Previous $14.7 Million
3.06%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding CERS
# of Institutions
165Shares Held
139MCall Options Held
100KPut Options Held
16K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl19.2MShares$23.6 Million0.22% of portfolio
-
Black Rock Inc. New York, NY13.9MShares$17.1 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY12.9MShares$15.8 Million0.18% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT8.53MShares$10.5 Million0.07% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.6.07MShares$7.47 Million0.01% of portfolio
About CERUS CORP
- Ticker CERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 177,090,000
- Market Cap $218M
- Description
- Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...